ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Effects of Donor Heavy Alcohol Use on Post-Heart Transplant Outcomes: Time to Abstain?

    J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, A. Shen, K. Nishihara, G. Jamero, L. Czer, F. Esmailian, J. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Donors with a history of heavy alcohol use have been suspected to possibly harbor a subclinical alcoholic cardiomyopathy with limited cardiac reserve. This problem…
  • 2020 American Transplant Congress

    The Association between Preoperative Hemodynamics and Right Ventricular Failure Following Implantation of Left Ventricular Assist Device

    D. Bhakta1, A. Alam2, J. S. van Zyl2, H. Zafar2, A. Aasim2, D. M. Meyer2, J. Felius2, S. Hall2, D. Wencker2

    1Texas A&M University College of Medicine, Dallas, TX, 2Baylor University Medical Center, Dallas, TX

    *Purpose: Right ventricular failure (RVF) following left ventricular assist device (LVAD) implantation is a common complication and associated with increased mortality. Clinical predictors contributing to…
  • 2020 American Transplant Congress

    Voriconazole Associated Adverse Drug Events and Drug Monitoring in Lung Transplant Recipients

    C. Y. Luo1, R. G. Nador2, R. D. Levy2, J. Yee2, L. Wei2, N. Partovi1

    1Vancouver General Hospital, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada

    *Purpose: Voriconazole is the drug of choice for prophylaxis and treatment of Aspergillus infection in lung transplant ( LTx) recipients. Voriconazole has a narrow therapeutic…
  • 2020 American Transplant Congress

    Bariatric Surgery for Congestive Heart Failure Patients Improves Access to Transplantation and Long-Term Survival

    R. A. Choudhury1, G. Hoeltzel2, H. B. Moore1, H. Yaffe1, D. Yoeli1, K. R. Dumon3, K. D. Conzen1, T. L. Nydam1

    1Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, 2Thomas Jefferson University Hospital, Philadelphia, PA, 3Department of Surgery, University of Colorado Hospital, Philadelphia, PA

    *Purpose: Obese patients with congestive heart failure (CHF) are often denied access to heart transplantation until they obtain significant weight loss to achieve a certain…
  • 2020 American Transplant Congress

    Resilience in Heart Transplant Candidates

    Y. T. Bui1, D. S. Yip2, B. W. Hardaway3, S. M. Dunlay4, S. Jowsey-Gregoire5, R. Benzo6, R. C. Daly7, M. A. Hathcock8, K. Thompson9, C. C. Kennedy10

    1Mayo Clinic Alix School of Medicine, Rochester, MN, 2Department of Transplantation, Mayo Clinic, Jacksonville, FL, 3Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ, 4Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 5Department of Psychiatry, Mayo Clinic, Rochester, MN, 6Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, 7Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, 8Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, 9Pulmonary Clinical Research Unit, Mayo Clinic, Rochester, MN, 10William J. von Liebig Center for Transplantation and Regenerative Medicine, Mayo Clinic, Rochester, MN

    *Purpose: Resilience is the capacity to adapt to or recover from adverse experiences. Our objective was to measure resilience in waitlisted, adult heart transplant candidates…
  • 2020 American Transplant Congress

    Effects of Alpha-1 Proteinase Replacement Continuation Post-Lung Transplantation in Alpha-1 Antitrypsin Deficiency: A Single Center Case Series

    M. Bremer, A. Feist, M. Mariski, G. Yung, T. Floreth, E. Schonhoft, G. Schooler, E. Golts, K. Afshar

    Lung Transplant, University of California San Diego, La Jolla, CA

    *Purpose: Alpha-1 antitrypsin deficiency (AATD) accounts for approximately 6% of all lung transplants (LTx) performed annually. The benefit of replacement with alpha-1 proteinase inhibitor (A1-PI)…
  • 2020 American Transplant Congress

    Recruitment in the Pediatric Heart Transplant TEAMMATE Trial: Observed vs. Expected

    K. P. Daly, L. A. Sleeper, L. J. Addonizio, J. C. Alejos, S. Auerbach, M. J. Bock, A. Butto, W. F. Carlo, C. Castleberry, W. J. Dreyer, B. Feingold, J. M. Lamour, E. L. Albers, S. A. Hollander, G. L. Klein, A. Lal, E. Pahl, D. Peng, A. R. Punnoose, J. W. Rossano, T. D. Ryan, J. Su, D. L. Sutcliffe, S. Zangwill, C. S. Almond

    TEAMMATE Trial Investigators, Boston, MA

    *Purpose: The TEAMMATE (Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients using the MATE Score) Trial is the first multicenter effort to address key scientific…
  • 2020 American Transplant Congress

    A Quality Improvement Project to Reduce the Risk of Alcohol Relapse after Liver Transplantation by Implementing a High-Risk Alcoholism Relapse Scale

    R. V. Tholen1, E. Bundy2

    1Transplant Nephrology, University of Maryland Medical Center, Baltimore, MD, 2School of Nursing, University of Maryland, Baltimore, Baltimore, MD

    *Purpose: Alcoholism is the leading cause of liver-related mortality worldwide. Liver transplantation is considered the only curative treatment for end-stage liver disease. Transplantation will reverse…
  • 2020 American Transplant Congress

    Brincidofovir for Adenovirus Disease in Adult Renal Transplant Recipients: A Case Series

    F. Zervou1, I. Zacharioudakis1, S. A. Mehta2, H. J. Neumann2

    1Infectious Diseases, New York University Langone, New York, NY, 2New York University Langone Transplant Institute, New York, NY

    *Purpose: Adenovirus infection can lead to disease in solid organ transplant recipients, including disease of the allograft. Treatment options for severe disease are limited. Brincidofovir…
  • 2020 American Transplant Congress

    The Negative Impact of Inherent Oxidative Stress in Marginal Lungs on Ex Vivo Lung Perfusion

    K. Noda1, B. J. Philips1, M. Velayutham2, T. Harano1, P. Reck dos Santos1, S. Shiva2, P. G. Sanchez1

    1Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, 2Department of Medicine, University of Pittsburgh, Pittsburgh, PA

    *Purpose: Identifying good quality grafts within the donor pool, ex vivo lung perfusion (EVLP) opens another window to evaluate grafts initially declined with marginal quality…
  • « Previous Page
  • 1
  • …
  • 375
  • 376
  • 377
  • 378
  • 379
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences